Inhibition of Integrin αvβ3-FAK-MAPK signaling constrains the invasion of T-ALL cells

ABSTRACT The role of adhesion receptor integrin αvβ3 in T-ALL was unclear. Firstly, we performed quantitative real-time PCR to assess medullary expression of integrin β3(ITGB3) in T-ALL patients and high ITGB3 expression was relevant with the central nervous system leukemia(CNSL) incidence. Decreasing of cell invasion was observed in Jurkat and Molt4 treated with integrin αvβ3 specific antibody and inhibitor as well as cells with ITGB3 interference. Further, phosphorylation of FAK, cRAF, MEK and ERK decreased in cells with integrin αvβ3 inhibition or interference. Invasion decreased in T-ALL cells treated with FAK and ERK inhibitors. In conclusion, inhibition of integrin αvβ3 signals significantly limits the cell invasion of T-ALL cells.

[1]  Xiaojuan Chen,et al.  A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group , 2022, Frontiers in Oncology.

[2]  Cheng Cheng,et al.  Prognostic Factors for CNS Control in Children with Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation. , 2021, Blood.

[3]  V. De Rosa,et al.  The DEL-1-β3 integrin axis promotes regulatory T cell responses during inflammation resolution. , 2020, The Journal of clinical investigation.

[4]  M. Loh,et al.  Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Worawat Wattanathana,et al.  Benzoxazine Dimer Analogue Targets Integrin β3 in Lung Cancer Cells and Suppresses Anoikis Resistance and Migration , 2020, AntiCancer Research.

[6]  Jeeyong Lee,et al.  Integrin αvβ3‐Akt signalling plays a role in radioresistance of melanoma , 2020, Experimental dermatology.

[7]  Chi-kong Li,et al.  Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG‐ALL‐2015 , 2020, Cancer medicine.

[8]  D. Calderwood,et al.  Chapter 22: Structural and signaling functions of integrins. , 2020, Biochimica et biophysica acta. Biomembranes.

[9]  B. Damania,et al.  Kaposi’s Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3 , 2019, Journal of Virology.

[10]  Huimin Shen,et al.  Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma , 2019, Journal of experimental & clinical cancer research : CR.

[11]  Xin Wen,et al.  Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3. , 2019, Cancer research.

[12]  S. Lompardía,et al.  Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines , 2019, Scientific Reports.

[13]  S. Del Vecchio,et al.  Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells , 2019, International journal of molecular sciences.

[14]  J. Qian,et al.  LINC00461 promotes cell migration and invasion in breast cancer through miR‐30a‐5p/integrin β3 axis , 2019, Journal of Cellular Biochemistry.

[15]  F. Giancotti,et al.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. , 2019, Cancer cell.

[16]  Li Zhao,et al.  Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling , 2019, Molecular Cancer.

[17]  Dan Yang,et al.  Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. , 2019, Cancer letters.

[18]  Yongzhuo Huang,et al.  Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery , 2019, Theranostics.

[19]  Yue Zhang,et al.  FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation , 2018, Cancer biology & therapy.

[20]  Julie M Gastier-Foster,et al.  Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Di Minno,et al.  Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins , 2018, International journal of molecular sciences.

[22]  Yi-Jin Gao,et al.  Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China , 2018, American journal of hematology.

[23]  Shengfeng Qiu,et al.  IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling , 2018, Translational oncology.

[24]  Ø. Bruserud,et al.  The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia , 2018, International Journal of Molecular Sciences.

[25]  Rosana Pelayo,et al.  T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. , 2017, Blood reviews.

[26]  S. Richon,et al.  Cancer-associated fibroblasts lead tumor invasion through integrin-β3–dependent fibronectin assembly , 2017, The Journal of cell biology.

[27]  B. Griffith,et al.  Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices. , 2017, Thrombosis research.

[28]  E. Traer,et al.  Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia , 2017, PloS one.

[29]  G. Di Minno,et al.  Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells , 2017, PloS one.

[30]  P. Kong,et al.  Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity , 2016, Oncotarget.

[31]  Wen-Chao Liu,et al.  BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK , 2016, Oncotarget.

[32]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[33]  Xia Li,et al.  EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis , 2015, Oncotarget.

[34]  F. Speleman,et al.  Novel biological insights in T-cell acute lymphoblastic leukemia. , 2015, Experimental hematology.

[35]  A. Vora,et al.  Update on biology and treatment of T-cell acute lymphoblastic leukaemia , 2015, Current opinion in pediatrics.

[36]  Xian-Jun Qu,et al.  Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer. , 2014, Pathology, research and practice.

[37]  D. Rognan,et al.  Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells. , 2014, Biochimica et biophysica acta.

[38]  D. Schlaepfer,et al.  FAK in cancer: mechanistic findings and clinical applications , 2014, Nature Reviews Cancer.

[39]  W. Slayton,et al.  Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia , 2014, Front. Oncol..

[40]  Fatima Al-Shahrour,et al.  In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. , 2013, Cancer cell.

[41]  M. Konopleva,et al.  Leukemia stem cells and microenvironment: biology and therapeutic targeting. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  B. Clotet,et al.  β5 Integrin Is the Major Contributor to the αv Integrin-Mediated Blockade of HIV-1 Replication , 2011, The Journal of Immunology.

[43]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[44]  T. Kamata,et al.  Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function , 2005, Journal of thrombosis and haemostasis : JTH.

[45]  R. Gelber,et al.  Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[47]  M Schwaiger,et al.  Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  N. Heerema,et al.  Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. , 1998, Blood.

[49]  H. Ostergaard,et al.  Cytotoxic T lymphocytes express a β3 integrin which can induce the phosphorylation of focal adhesion kinase and the related PYK‐2 , 1997, European journal of immunology.

[50]  F. Behm,et al.  Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.

[51]  A. Gotoh,et al.  Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. , 1995, Experimental hematology.

[52]  H. Sather,et al.  Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  D. Woodley,et al.  Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. , 1994, The Journal of biological chemistry.

[54]  F. Behm,et al.  Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. , 1993, The New England journal of medicine.